Last reviewed · How we verify

NCT06008626: ARCTIC-3

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Recruiting now NA Last updated 24 February 2026
What this trial tests

NA trial testing Cryosa Procedure in Obstructive Sleep Apnea of Adult in 25 participants. Currently enrolling.

Timeline
12 September 2023
Primary endpoint
30 June 2026
31 March 2028

Quick facts

Lead sponsorCryosa, Inc.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date12 September 2023
Primary completion30 June 2026
Estimated completion31 March 2028
Sites8 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cryosa, Inc.

Who can join

Adults 22 to 70, any sex, with Obstructive Sleep Apnea of Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in patients with moderate to severe OSA. The study will also evaluate the chronic performance of the Cryosa system and collect clinical measures for therapy effectiveness that will be used to demonstrate safety and effectiveness in the next clinical study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea of Adult

Currently open trials in the same condition.

Other Cryosa, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06008626.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing